Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 542

The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.

ACE2, angiotensin‐(1‐7) and Mas receptor axis in inflammation and fibrosis

Open access
Simões e Silva, AC, Silveira, KD, Ferreira, AJ, Teixeira, MM·2013·British Journal of Pharmacology

Abstract

Recent advances have improved our understanding of the renin‐angiotensin system (RAS). These have included the recognition that angiotensin (A ng)‐(1‐7) is a biologically active product of the RAS cascade. The identification of the ACE homologue ACE2, which forms A ng‐(1‐7) from A ng II, and the GPCR M as as an A ng‐(1‐7) receptor have provided the necessary biochemical and molecular background and tools to study the biological significance of A ng‐(1‐7). Most available evidence supports a counter‐regulatory role for A ng‐(1‐7) by opposing many actions of A ng II on AT 1 receptors, especially vasoconstriction and proliferation. Many studies have now shown that A ng‐(1‐7) by acting via M as receptor exerts inhibitory effects on inflammation and on vascular and cellular growth mechanisms. A ng‐(1‐7) has also been shown to reduce key signalling pathways and molecules thought to be relevant for fibrogenesis. Here, we review recent findings related to the function of the ACE2/A ng‐(1‐7)/M as axis and focus on the role of this axis in modifying processes associated with acute and chronic inflammation, including leukocyte influx, fibrogenesis and proliferation of certain cell types. More attention will be given to the involvement of the ACE2/A ng‐(1‐7)/M as axis in the context of renal disease because of the known relevance of the RAS for the function of this organ and for the regulation of kidney inflammation and fibrosis. Taken together, this knowledge may help in paving the way for the development of novel treatments for chronic inflammatory and renal diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.12159

Cites

167 of 167 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 167 references

Cited by

Metadata

Authors
Simões e Silva, A., Silveira, K., Ferreira, A., & Teixeira, M.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2013-05-16
Volume
169
Issue
3
Pages
477-492
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2138043907
Cited by
542
References
167
FWCI
14.83
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.